StockData
Odyssey Health, Inc. logo

Odyssey Health, Inc. (ODYY) stock

ODYYOTCSurgical & Medical Instruments & ApparatusFiscal year ends July 31
Số liệu tài chính tới Q4 năm tài chính 2026, quý kết thúc ngày Jul 31, 2026Last filing: 10-K on Oct 28, 2026Score 0/30
$0.01−0.00 (-16.25%)

Close on Oct 19, 2026Market cap $746.34KP/E –Yield –

Odyssey Health r&d expenses

Research and development expenses are spending on new products and technology.

Odyssey Health's R&D Expenses for the twelve months ending Jul 31, 2025 was $22.63K, down 59.0% year over year. For fiscal 2026 it was $0, down 100.0% from the year before. The highest annual figure on record is $23.01M in fiscal 2019.

Annual r&d expenses

PeriodPeriod endValueChange
FY2026Jul 31, 2026$0-100.0%
FY2025Jul 31, 2025$22.63K-59.0%
FY2024Jul 31, 2024$55.17K-67.5%
FY2023Jul 31, 2023$170.00K-89.6%
FY2021Jul 31, 2021$1.63M+7967.4%
FY2020Jul 31, 2020$20.24K-99.9%
FY2019Jul 31, 2019$23.01M–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q4 FY2025CQ2 2025Jul 31, 2025$22.63K–
Q3 FY2025CQ1 2025Apr 30, 2025$0–
Q2 FY2025CQ4 2024Jan 31, 2025$0-100.0%
Q1 FY2025CQ3 2024Oct 31, 2024$0-100.0%
Q4 FY2024CQ2 2024Jul 31, 2024$0–
Q3 FY2024CQ1 2024Apr 30, 2024$0–
Q2 FY2024CQ4 2023Jan 31, 2024$42.77K-74.8%
Q1 FY2024CQ3 2023Oct 31, 2023$23.00K-95.0%
Q4 FY2023CQ2 2023Jul 31, 2023$0-100.0%
Q3 FY2023CQ1 2023Apr 30, 2023$0-100.0%
Q2 FY2023CQ4 2022Jan 31, 2023$170.00K-70.0%
Q2 FY2022CQ4 2021Jan 31, 2022$460.72K+981.0%
Q1 FY2022CQ3 2021Oct 31, 2021$322.50K–
Q4 FY2021CQ2 2021Jul 31, 2021$1.02M+9905.0%
Q3 FY2021CQ1 2021Apr 30, 2021$565.76K–
Q2 FY2021CQ4 2020Jan 31, 2021$42.62K–
Q1 FY2021CQ3 2020Oct 31, 2020$0–
Q4 FY2020CQ2 2020Jul 31, 2020$10.24K–
Q3 FY2020CQ1 2020Apr 30, 2020$0–
Q1 FY2018CQ3 2017Oct 31, 2017$0–
Q3 FY2017CQ1 2017Apr 30, 2017$0–
Q2 FY2017CQ4 2016Jan 31, 2017$0–
Q1 FY2017CQ3 2016Oct 31, 2016$0–

More Odyssey Health figures

See a number that looks wrong?